3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
fludarabine
17
Cyclophosphamide
15
Specimen Handling
14
Biopsy
12
fludarabine phosphate
11
Melphalan
10
Cytarabine
10
Busulfan
10
Mycophenolic Acid
9
venetoclax
8
Whole-Body Irradiation
8
Tacrolimus
8
decitabine and cedazuridine drug combination
7
Granulocyte Colony-Stimulating Factor
7
Injections
6
Cyclosporine
6
Azacitidine
6
Stem Cell Transplantation
5
Sirolimus
5
Filgrastim
5
X-Rays
4
Thiotepa
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
CPX-351
4
ruxolitinib
3
Magnetic Resonance Spectroscopy
3
Hematopoietic Stem Cell Transplantation
3
Decitabine
3
treosulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
tislelizumab
×
30 days
×
Clear all
No trials found.